Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Clostridium botulinum Putative sporulation transcription regulator WhiA (whiA) CSB-YP418794CWW
CSB-EP418794CWW
CSB-BP418794CWW
CSB-MP418794CWW
CSB-EP418794CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum UvrABC system protein C (uvrC), partial CSB-YP418795CWW
CSB-EP418795CWW
CSB-BP418795CWW
CSB-MP418795CWW
CSB-EP418795CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 30S ribosomal protein S4 A (rpsD1) CSB-YP418796CWW
CSB-EP418796CWW
CSB-BP418796CWW
CSB-MP418796CWW
CSB-EP418796CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 30S ribosomal protein S5 (rpsE) CSB-YP418797CWW
CSB-EP418797CWW
CSB-BP418797CWW
CSB-MP418797CWW
CSB-EP418797CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 50S ribosomal protein L14 (rplN) CSB-YP418798CWW
CSB-EP418798CWW
CSB-BP418798CWW
CSB-MP418798CWW
CSB-EP418798CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 50S ribosomal protein L33 (rpmG) CSB-YP418799CWW
CSB-EP418799CWW
CSB-BP418799CWW
CSB-MP418799CWW
CSB-EP418799CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Formate--tetrahydrofolate ligase (fhs), partial CSB-YP418800CWW
CSB-EP418800CWW
CSB-BP418800CWW
CSB-MP418800CWW
CSB-EP418800CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Ribosomal RNA large subunit methyltransferase H (rlmH) CSB-YP418801CWW
CSB-EP418801CWW
CSB-BP418801CWW
CSB-MP418801CWW
CSB-EP418801CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum 30S ribosomal protein S6 (rpsF) CSB-YP418802CWW
CSB-EP418802CWW
CSB-BP418802CWW
CSB-MP418802CWW
CSB-EP418802CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Clostridium botulinum Ribonuclease P protein component (rnpA) CSB-YP418803CWW
CSB-EP418803CWW
CSB-BP418803CWW
CSB-MP418803CWW
CSB-EP418803CWW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus subsp. cytotoxis UPF0133 protein Bcer98_0019 (Bcer98_0019) CSB-YP418804BOK
CSB-EP418804BOK
CSB-BP418804BOK
CSB-MP418804BOK
CSB-EP418804BOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus subsp. cytotoxis 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase (ispE) CSB-YP418805BOK
CSB-EP418805BOK
CSB-BP418805BOK
CSB-MP418805BOK
CSB-EP418805BOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus subsp. cytotoxis Putative ATP:guanido phosphotransferase Bcer98_0075 (Bcer98_0075) CSB-YP418806BOK
CSB-EP418806BOK
CSB-BP418806BOK
CSB-MP418806BOK
CSB-EP418806BOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus subsp. cytotoxis 50S ribosomal protein L10 (rplJ) CSB-YP418807BOK
CSB-EP418807BOK
CSB-BP418807BOK
CSB-MP418807BOK
CSB-EP418807BOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus subsp. cytotoxis 30S ribosomal protein S10 (rpsJ) CSB-YP418808BOK
CSB-EP418808BOK
CSB-BP418808BOK
CSB-MP418808BOK
CSB-EP418808BOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus subsp. cytotoxis 30S ribosomal protein S3 (rpsC) CSB-YP418809BOK
CSB-EP418809BOK
CSB-BP418809BOK
CSB-MP418809BOK
CSB-EP418809BOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus subsp. cytotoxis 30S ribosomal protein S8 (rpsH) CSB-YP418810BOK
CSB-EP418810BOK
CSB-BP418810BOK
CSB-MP418810BOK
CSB-EP418810BOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus subsp. cytotoxis 50S ribosomal protein L17 (rplQ) CSB-YP418811BOK
CSB-EP418811BOK
CSB-BP418811BOK
CSB-MP418811BOK
CSB-EP418811BOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus subsp. cytotoxis 60 kDa chaperonin (groL), partial CSB-YP418812BOK
CSB-EP418812BOK
CSB-BP418812BOK
CSB-MP418812BOK
CSB-EP418812BOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus cereus subsp. cytotoxis DNA ligase (ligA), partial CSB-YP418813BOK
CSB-EP418813BOK
CSB-BP418813BOK
CSB-MP418813BOK
CSB-EP418813BOK-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問,涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>